Global PCSK9-targeted Therapy Production, Demand and Key Producers, 2022-2028

November 2022 | 102 pages | ID: G35A8F03CD95EN
GlobalInfoResearch

Abstracts

This report studies the global PCSK9-targeted Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for PCSK9-targeted Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of PCSK9-targeted Therapy that contribute to its increasing demand across many markets.

The global PCSK9-targeted Therapy market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global PCSK9-targeted Therapy total market, 2017-2028, (USD Million)

Global PCSK9-targeted Therapy total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: PCSK9-targeted Therapy total market, key domestic companies and share, (USD Million)

Global PCSK9-targeted Therapy revenue by player and market share 2017-2022, (USD Million)

Global PCSK9-targeted Therapy total market by Type, CAGR, 2017-2028, (USD Million)

Global PCSK9-targeted Therapy total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global PCSK9-targeted Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, Regeneron, Amgen, Novartis, Hengrui Pharma, TopAlliance Biosciences, Innovent Biologics, Inc. and Akeso, Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PCSK9-targeted Therapy market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global PCSK9-targeted Therapy Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global PCSK9-targeted Therapy Market, Segmentation by Type

• Subcutaneous Injection
• Oral

Global PCSK9-targeted Therapy Market, Segmentation by Application

• CVD
• Tumor
• Acne
• Others

Companies Profiled:

• Novo Nordisk
• Sanofi
• Regeneron
• Amgen
• Novartis
• Hengrui Pharma
• TopAlliance Biosciences
• Innovent Biologics, Inc.
• Akeso, Inc

Key Questions Answered

1. How big is the global PCSK9-targeted Therapy market?

2. What is the demand of the global PCSK9-targeted Therapy market?

3. What is the year over year growth of the global PCSK9-targeted Therapy market?

4. What is the total value of the global PCSK9-targeted Therapy market?

5. Who are the major players in the global PCSK9-targeted Therapy market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 PCSK9-targeted Therapy Introduction
1.2 World PCSK9-targeted Therapy Market Size & Forecast (2017 & 2021 & 2028)
1.3 World PCSK9-targeted Therapy Total Market by Region
  1.3.1 World PCSK9-targeted Therapy Market Size by Region (2017-2028)
  1.3.2 United States PCSK9-targeted Therapy Market Size (2017-2028)
  1.3.3 China PCSK9-targeted Therapy Market Size (2017-2028)
  1.3.4 Europe PCSK9-targeted Therapy Market Size (2017-2028)
  1.3.5 Japan PCSK9-targeted Therapy Market Size (2017-2028)
  1.3.6 South Korea PCSK9-targeted Therapy Market Size (2017-2028)
  1.3.7 ASEAN PCSK9-targeted Therapy Market Size (2017-2028)
  1.3.8 India PCSK9-targeted Therapy Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 PCSK9-targeted Therapy Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 PCSK9-targeted Therapy Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD PCSK9-TARGETED THERAPY COMPANIES COMPETITIVE ANALYSIS

2.1 World PCSK9-targeted Therapy Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global PCSK9-targeted Therapy Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for PCSK9-targeted Therapy in 2021
  2.2.3 Global Concentration Ratios (CR8) for PCSK9-targeted Therapy in 2021
2.3 PCSK9-targeted Therapy Company Evaluation Quadrant
2.4 PCSK9-targeted Therapy Market: Overall Company Footprint Analysis
  2.4.1 PCSK9-targeted Therapy Market: Region Footprint
  2.4.2 PCSK9-targeted Therapy Market: Company Product Type Footprint
  2.4.3 PCSK9-targeted Therapy Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: PCSK9-targeted Therapy Market Comparison
  3.1.1 United States VS China: PCSK9-targeted Therapy Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: PCSK9-targeted Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States PCSK9-targeted Therapy Major Players and Market Share, 2017-2022
  3.2.1 Major Players of PCSK9-targeted Therapy in United States, Headquarters (States, Country)
  3.2.2 United States PCSK9-targeted Therapy Revenue by Domestic Player, (2017-2022)
3.3 China PCSK9-targeted Therapy Major Players and Market Share, 2017-2022
  3.3.1 Major Players of PCSK9-targeted Therapy in China, Headquarters (Province, Country)
  3.3.2 China PCSK9-targeted Therapy Revenue by Domestic Player, (2017-2022)
3.4 Rest of World PCSK9-targeted Therapy Major Players and Market Share, 2017-2022
  3.4.1 Major Players of PCSK9-targeted Therapy in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World PCSK9-targeted Therapy Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World PCSK9-targeted Therapy Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Subcutaneous Injection
  4.2.2 Oral
4.3 Market Segment by Type
  4.3.1 World PCSK9-targeted Therapy Market Size by Type (2017-2022)
  4.3.2 World PCSK9-targeted Therapy Market Size by Type (2023-2028)
  4.3.3 World PCSK9-targeted Therapy Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World PCSK9-targeted Therapy Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 CVD
  5.2.2 Tumor
  5.2.3 Acne
  5.2.4 Others
  5.2.5 Others
5.3 Market Segment by Application
  5.3.1 World PCSK9-targeted Therapy Market Size by Application (2017-2022)
  5.3.2 World PCSK9-targeted Therapy Market Size by Application (2023-2028)
  5.3.3 World PCSK9-targeted Therapy Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Novo Nordisk
  6.1.1 Novo Nordisk Details
  6.1.2 Novo Nordisk Major Business
  6.1.3 Novo Nordisk PCSK9-targeted Therapy Product and Services
  6.1.4 Novo Nordisk PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Novo Nordisk Recent Developments/Updates
  6.1.6 Novo Nordisk Competitive Strengths & Weaknesses
6.2 Sanofi
  6.2.1 Sanofi Details
  6.2.2 Sanofi Major Business
  6.2.3 Sanofi PCSK9-targeted Therapy Product and Services
  6.2.4 Sanofi PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Sanofi Recent Developments/Updates
  6.2.6 Sanofi Competitive Strengths & Weaknesses
6.3 Regeneron
  6.3.1 Regeneron Details
  6.3.2 Regeneron Major Business
  6.3.3 Regeneron PCSK9-targeted Therapy Product and Services
  6.3.4 Regeneron PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Regeneron Recent Developments/Updates
  6.3.6 Regeneron Competitive Strengths & Weaknesses
6.4 Amgen
  6.4.1 Amgen Details
  6.4.2 Amgen Major Business
  6.4.3 Amgen PCSK9-targeted Therapy Product and Services
  6.4.4 Amgen PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 Amgen Recent Developments/Updates
  6.4.6 Amgen Competitive Strengths & Weaknesses
6.5 Novartis
  6.5.1 Novartis Details
  6.5.2 Novartis Major Business
  6.5.3 Novartis PCSK9-targeted Therapy Product and Services
  6.5.4 Novartis PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Novartis Recent Developments/Updates
  6.5.6 Novartis Competitive Strengths & Weaknesses
6.6 Hengrui Pharma
  6.6.1 Hengrui Pharma Details
  6.6.2 Hengrui Pharma Major Business
  6.6.3 Hengrui Pharma PCSK9-targeted Therapy Product and Services
  6.6.4 Hengrui Pharma PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.6.5 Hengrui Pharma Recent Developments/Updates
  6.6.6 Hengrui Pharma Competitive Strengths & Weaknesses
6.7 TopAlliance Biosciences
  6.7.1 TopAlliance Biosciences Details
  6.7.2 TopAlliance Biosciences Major Business
  6.7.3 TopAlliance Biosciences PCSK9-targeted Therapy Product and Services
  6.7.4 TopAlliance Biosciences PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.7.5 TopAlliance Biosciences Recent Developments/Updates
  6.7.6 TopAlliance Biosciences Competitive Strengths & Weaknesses
6.8 Innovent Biologics, Inc.
  6.8.1 Innovent Biologics, Inc. Details
  6.8.2 Innovent Biologics, Inc. Major Business
  6.8.3 Innovent Biologics, Inc. PCSK9-targeted Therapy Product and Services
  6.8.4 Innovent Biologics, Inc. PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.8.5 Innovent Biologics, Inc. Recent Developments/Updates
  6.8.6 Innovent Biologics, Inc. Competitive Strengths & Weaknesses
6.9 Akeso, Inc
  6.9.1 Akeso, Inc Details
  6.9.2 Akeso, Inc Major Business
  6.9.3 Akeso, Inc PCSK9-targeted Therapy Product and Services
  6.9.4 Akeso, Inc PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022)
  6.9.5 Akeso, Inc Recent Developments/Updates
  6.9.6 Akeso, Inc Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of PCSK9-targeted Therapy and Key Manufacturers
7.2 PCSK9-targeted Therapy Manufacturing Costs
7.3 PCSK9-targeted Therapy Production Process
7.4 PCSK9-targeted Therapy Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for PCSK9-targeted Therapy Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 PCSK9-targeted Therapy Typical Distributors
8.3 PCSK9-targeted Therapy Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World PCSK9-targeted Therapy Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World PCSK9-targeted Therapy Market Size by Region (2017-2022) & (USD Million)
Table 3. World PCSK9-targeted Therapy Market Size by Region (2023-2028) & (USD Million)
Table 4. World PCSK9-targeted Therapy Market Size Market Share by Region (2017-2022)
Table 5. World PCSK9-targeted Therapy Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World PCSK9-targeted Therapy Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key PCSK9-targeted Therapy Players in 2021
Table 9. World PCSK9-targeted Therapy Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global PCSK9-targeted Therapy Company Evaluation Quadrant
Table 11. Head Office of Key PCSK9-targeted Therapy Player
Table 12. PCSK9-targeted Therapy Market: Company Product Type Footprint
Table 13. PCSK9-targeted Therapy Market: Company Product Application Footprint
Table 14. PCSK9-targeted Therapy Mergers & Acquisitions Activity
Table 15. United States VS China PCSK9-targeted Therapy Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of PCSK9-targeted Therapy in United States, Headquarters (States, Country)
Table 17. United States PCSK9-targeted Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States PCSK9-targeted Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of PCSK9-targeted Therapy in China, Company Headquarters (Province, Country)
Table 20. China PCSK9-targeted Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China PCSK9-targeted Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of PCSK9-targeted Therapy in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World PCSK9-targeted Therapy Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World PCSK9-targeted Therapy Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World PCSK9-targeted Therapy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World PCSK9-targeted Therapy Revenue by Type (2017-2022) & (USD Million)
Table 27. World PCSK9-targeted Therapy Revenue by Type (2023-2028) & (USD Million)
Table 28. World PCSK9-targeted Therapy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World PCSK9-targeted Therapy Revenue by Application (2017-2022) & (USD Million)
Table 30. World PCSK9-targeted Therapy Revenue by Application (2023-2028) & (USD Million)
Table 31. Novo Nordisk Basic Information, Area Served and Competitors
Table 32. Novo Nordisk Major Business
Table 33. Novo Nordisk PCSK9-targeted Therapy Product and Services
Table 34. Novo Nordisk PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Novo Nordisk Recent Developments/Updates
Table 36. Novo Nordisk Competitive Strengths & Weaknesses
Table 37. Sanofi Basic Information, Area Served and Competitors
Table 38. Sanofi Major Business
Table 39. Sanofi PCSK9-targeted Therapy Product and Services
Table 40. Sanofi PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Sanofi Recent Developments/Updates
Table 42. Sanofi Competitive Strengths & Weaknesses
Table 43. Regeneron Basic Information, Area Served and Competitors
Table 44. Regeneron Major Business
Table 45. Regeneron PCSK9-targeted Therapy Product and Services
Table 46. Regeneron PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Regeneron Recent Developments/Updates
Table 48. Regeneron Competitive Strengths & Weaknesses
Table 49. Amgen Basic Information, Area Served and Competitors
Table 50. Amgen Major Business
Table 51. Amgen PCSK9-targeted Therapy Product and Services
Table 52. Amgen PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Amgen Recent Developments/Updates
Table 54. Amgen Competitive Strengths & Weaknesses
Table 55. Novartis Basic Information, Area Served and Competitors
Table 56. Novartis Major Business
Table 57. Novartis PCSK9-targeted Therapy Product and Services
Table 58. Novartis PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Novartis Recent Developments/Updates
Table 60. Novartis Competitive Strengths & Weaknesses
Table 61. Hengrui Pharma Basic Information, Area Served and Competitors
Table 62. Hengrui Pharma Major Business
Table 63. Hengrui Pharma PCSK9-targeted Therapy Product and Services
Table 64. Hengrui Pharma PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Hengrui Pharma Recent Developments/Updates
Table 66. Hengrui Pharma Competitive Strengths & Weaknesses
Table 67. TopAlliance Biosciences Basic Information, Area Served and Competitors
Table 68. TopAlliance Biosciences Major Business
Table 69. TopAlliance Biosciences PCSK9-targeted Therapy Product and Services
Table 70. TopAlliance Biosciences PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. TopAlliance Biosciences Recent Developments/Updates
Table 72. TopAlliance Biosciences Competitive Strengths & Weaknesses
Table 73. Innovent Biologics, Inc. Basic Information, Area Served and Competitors
Table 74. Innovent Biologics, Inc. Major Business
Table 75. Innovent Biologics, Inc. PCSK9-targeted Therapy Product and Services
Table 76. Innovent Biologics, Inc. PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Innovent Biologics, Inc. Recent Developments/Updates
Table 78. Akeso, Inc Basic Information, Area Served and Competitors
Table 79. Akeso, Inc Major Business
Table 80. Akeso, Inc PCSK9-targeted Therapy Product and Services
Table 81. Akeso, Inc PCSK9-targeted Therapy Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 82. PCSK9-targeted Therapy Raw Material
Table 83. Key Manufacturers of PCSK9-targeted Therapy Raw Materials
Table 84. PCSK9-targeted Therapy Typical Distributors
Table 85. PCSK9-targeted Therapy Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. PCSK9-targeted Therapy Picture
Figure 2. World PCSK9-targeted Therapy Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World PCSK9-targeted Therapy Total Market Size (2017-2028) & (USD Million)
Figure 4. World PCSK9-targeted Therapy Market Size Market Share by Region (2017-2028)
Figure 5. United States PCSK9-targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 6. China PCSK9-targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 7. Europe PCSK9-targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 8. Japan PCSK9-targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 9. South Korea PCSK9-targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN PCSK9-targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 11. India PCSK9-targeted Therapy Market Size (2017-2028) & (USD Million)
Figure 12. PCSK9-targeted Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of PCSK9-targeted Therapy by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for PCSK9-targeted Therapy Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for PCSK9-targeted Therapy Markets in 2021
Figure 17. United States VS China: PCSK9-targeted Therapy Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World PCSK9-targeted Therapy Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World PCSK9-targeted Therapy Market Size Market Share by Type in 2021
Figure 20. Subcutaneous Injection
Figure 21. Oral
Figure 22. World PCSK9-targeted Therapy Market Size Market Share by Type (2017-2028)
Figure 23. World PCSK9-targeted Therapy Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 24. World PCSK9-targeted Therapy Market Size Market Share by Application in 2021
Figure 25. CVD
Figure 26. Tumor
Figure 27. Acne
Figure 28. Others
Figure 29. World PCSK9-targeted Therapy Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of PCSK9-targeted Therapy in 2021
Figure 31. Manufacturing Process Analysis of PCSK9-targeted Therapy
Figure 32. PCSK9-targeted Therapy Industrial Chain
Figure 33. Distribution Channel Breakdown for PCSK9-targeted Therapy Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source